AI assistant
CONMED Corp — Director's Dealing 2014
Jun 3, 2014
31971_dirs_2014-06-03_1bdd5144-cf6e-41ba-b16c-1b07ef4f9527.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2014-06-01
Reporting Person: CORASANTI JOSEPH J (President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-06-01 | Common Stock | M | 5000 | — | Acquired | 119148 | Direct |
| 2014-06-01 | Common Stock | F | 1804 | $44.90 | Disposed | 117344 | Direct |
| 2014-06-01 | Common Stock | M | 4000 | — | Acquired | 121344 | Direct |
| 2014-06-01 | Common Stock | F | 1443 | $44.90 | Disposed | 119901 | Direct |
| 2014-06-01 | Common Stock | M | 5000 | — | Acquired | 124901 | Direct |
| 2014-06-01 | Common Stock | F | 1804 | $44.90 | Disposed | 123097 | Direct |
| 2014-06-01 | Common Stock | M | 5000 | — | Acquired | 128097 | Direct |
| 2014-06-01 | Common Stock | F | 1804 | $44.90 | Disposed | 126293 | Direct |
| 2014-06-01 | Common Stock | M | 5000 | — | Acquired | 131293 | Direct |
| 2014-06-01 | Common Stock | F | 1804 | $44.90 | Disposed | 129489 | Direct |
| 2014-06-01 | Common Stock | M | 5000 | — | Acquired | 134489 | Direct |
| 2014-06-01 | Common Stock | F | 1804 | $44.90 | Disposed | 132685 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 5000 | Disposed | 2019-06-01 | Common Stock (5000) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 4000 | Disposed | 2019-10-30 | Common Stock (4000) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 5000 | Disposed | 2020-06-01 | Common Stock (5000) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 5000 | Disposed | 2021-06-01 | Common Stock (5000) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 5000 | Disposed | 2022-06-01 | Common Stock (5000) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | M | 5000 | Disposed | 2023-06-01 | Common Stock (5000) | Direct |
| 2014-06-01 | Rsus (restricted Stock Units) | $0 | A | 16250 | Acquired | 2024-06-01 | Common Stock (16250) | Direct |
| 2014-06-01 | Sars (Stock Appreciation Rights) | $44.90 | A | 40625 | Acquired | 2024-06-01 | Common Stock (40625) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting 20% each year over a five year period with the first 20% tranche to vest on June 1, 2010 with each successive 20% tranche to vest on June 1 the following year.
F3: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.